Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Kardiologiia|April 16, 2023
[Diastolic heart failure: 20 years later. Сurrent issues of pathoge-nesis, diagnosis and treatment of heart failure with preserved LVEF]F T Ageev, A G OvchinnikovKardiologiia|August 22, 2022
[Treatment of patients with heart failure and preserved ejection fraction: reliance on clinical phenotypes]F T Ageev, A G OvchinnikovKardiologiia|November 16, 2023
[Heart Failure With Low and Preserved Left Ventricular Ejection Fraction - are These Two Different Independent Diseases or One Disease, but at Different Stages of its Progression? How Does This Affect the Choice of Therapy and Its Effectiveness?]F T Ageev, A G OvchinnikovKardiologiia|January 13, 2023
[Рossibility of using European (HFA-PEFF) and American (H2FPEF) algorithms for diagnosing heart failure with preserved ejection fraction in Russian clinical practice]F T Ageev, E B Yarovaya, A G OvchinnikovTerapevticheskii Arkhiv|June 23, 2009
[Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy]A G Ovchinnikov, V M Serbul, F T AgeevKardiologiia|July 20, 2023
[What is "normal left ventricular ejection fraction" and its relationship with the pathogenesis and effectiveness of the treatment of heart failure]F T Ageev, A G Ovchinnikov, S F Ageeva, et al.Kardiologiia|December 26, 2017
[Left ventricular dysfunction in hypertensive heart: Current view of the pathogenesis and treatment]F T Ageev, A G Ovchinnikov, M V Ozhereljeva, et al.Kardiologiia|July 28, 2010
[Clinical, hemodynamic and neurohumoral effects of switching patients with chronic heart failure from not recommended -adrenoblockers to bisoprolol in ambulatory practice]F T Ageev, E S Zhubrina, A G Ovchinnikov, et al.Kardiologiia|January 25, 2021
The Role of Neprilysin Inhibitors in the Treatment of Heart Failure with Preserved Ejection FractionA G Ovchinnikov, A D Gvozdeva, Z N Blankova, et al.Pageof 9